Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2

被引:151
作者
Nagy, P
Vereb, G
Sebestyén, Z
Horváth, G
Lockett, SJ
Damjanovich, S
Park, JW
Jovin, TM
Szöllosi, J
机构
[1] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Hungarian Acad Sci, Cell Biophys Workgrp, H-4012 Debrecen, Hungary
[3] Max Planck Inst Biophys Chem, Dept Mol Biol, D-37077 Gottingen, Germany
[4] Lawrence Berkeley Lab, Div Life Sci, Bioimaging Grp, Berkeley, CA 94720 USA
[5] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA
关键词
ErbB proteins; lipid rafts; breast cancer; fluorescence resonance energy transfer;
D O I
10.1242/jcs.00118
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The ErbB family of transmembrane receptor tyrosine kinases plays an important role in the pathogenesis of many cancers. The four members of the family, ErbB1-4, form various homo- and heterodimers during the course of signal transduction. A second hierarchical level of molecular associations involving 10(2)-10(3) molecules, termed large-scale clustering, has also been identified, but the regulatory factors and biological consequences of such structures have not been systematically evaluated. In this report, we describe the states of association of ErbB2 and their relationship to local ErbB3 density and lipid rafts based on quantitative fluorescence microscopy of SKBR-3 breast cancer cells. Clusters of ErbB2 colocalized with lipid rafts identified by the GM1-binding B subunit of cholera toxin. Pixel-by-pixel analysis of fluorescence resonance energy transfer between labeled antibodies indicated that the homoassociation (homodimerization) of ErbB2 was proportional to the local density of ErbB2 and inversely proportional to that of ErbB3 and of the raft-specific lipid GM1. Crosslinking lipid rafts with the B subunit of cholera toxin caused dissociation of the rafts and ErbB2 clusters, an effect that was independent of the cytoskeletal anchoring of ErbB2. Crosslinking also decreased ErbB2-ErbB3 heteroassociation and the EGF- and heregulin-induced tyrosine phosphorylation of Shc. When cells were treated with the anti-ErbB2 monoclonal antibody 4D5 (parent murine version of Trastuzumab used in the immunotherapy of breast cancer), internalization of the antibody was inhibited by crosslinking of lipid rafts, but the antiproliferative activity of 4D5 was retained and even enhanced. We conclude that local densities of ErbB2 and ErbB3, as well as the lipid environment profoundly influence the association properties and biological function of ErbB2.
引用
收藏
页码:4251 / 4262
页数:12
相关论文
共 58 条
[1]   The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions [J].
Alroy, I ;
Yarden, Y .
FEBS LETTERS, 1997, 410 (01) :83-86
[2]   Cell biology - A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains [J].
Anderson, RGW ;
Jacobson, K .
SCIENCE, 2002, 296 (5574) :1821-1825
[3]  
Baeckström D, 2000, INT J ONCOL, V16, P1081
[4]   Heregulin degradation in the absence of rapid receptor-mediated internalization [J].
Baulida, J ;
Carpenter, G .
EXPERIMENTAL CELL RESEARCH, 1997, 232 (01) :167-172
[5]  
Baulida J, 1996, J BIOL CHEM, V271, P5251
[6]   Modification of membrane cholesterol level affects expression and clustering of class I HLA molecules at the surface of JY human lymphoblasts [J].
Bodnar, A ;
Jenei, A ;
Bene, L ;
Damjanovich, S ;
Matko, J .
IMMUNOLOGY LETTERS, 1996, 54 (2-3) :221-226
[7]  
Brock R, 2001, J CELL SCI, V114, P2437
[8]   A unified model of c-erbB receptor homo- and heterodimerisation [J].
Chamberlin, SG ;
Davies, DE .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1998, 1384 (02) :223-232
[9]   Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease [J].
Cobleigh, MA ;
Vogel, CL ;
Tripathy, D ;
Robert, NJ ;
Scholl, S ;
Fehrenbacher, L ;
Wolter, JM ;
Paton, V ;
Shak, S ;
Lieberman, G ;
Slamon, DJ .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2639-2648
[10]  
Demandolx D., 1997, Bioimaging, V5, P159, DOI 10.1002/1361-6374(199709)5:3<159::AID-BIO10>3.3.CO